Streetbeat News

CTCX

Carmell Therapeutics Corporation

https://www.carmellrx.com

Industry

Biotechnology

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company, announced the completion of their Gold Limited Edition Exclusive product for launch in March 2024, along with the development of 9 other skincare products for release in Spring and Summer 2024. These products, including a men's line and haircare products, utilize the Carmell SecretomeTM technology and a novel micellar nanoparticle formulation, avoiding harmful excipients. Manufactured in-house at their Pittsburgh facility, Carmell's products meet and surpass current and proposed regulatory standards.

Portfolio Pulse from Happy Mohamed

February 26, 2024 | 1:33 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Gainers included Inovio Pharmaceuticals (INO), NanoString Technologies (NSTG), Scinai Immunotherapeutics (SCNI), Cyclerion Therapeutics (CYCN), Carmell Therapeutics (CTCX), and Vicarious Surgical (RBOT). Losers included Akero Therapeutics (AKRO), Athersys (ATHX), 89bio (ETNB), Ventyx Biosciences (VTYX), Protagenic Therapeutics (PTIX), and Nuwellis (NUWE).

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 5:31 pm

Axolotl, a client of Moonshot, has announced a merger with Carmell Therapeutics. Upon closing, Axolotl's shareholders will receive $65M in CTCX stock and could gain up to $75M in potential milestone equity payments.

Portfolio Pulse from Bill Haddad

September 12, 2023 | 4:47 pm

Axolotl, a client of Moonshot, has announced a merger with Carmell Therapeutics. Upon closing, Axolotl's shareholders will receive $65M in CTCX stock and could gain up to $65M in potential milestone equity payments.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 4:39 pm

Carmell Therapeutics Corporation (CTCX) has successfully completed its post-merger integration with Axolotl Biologix. The company has unveiled a new organizational structure that emphasizes aesthetics.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 5:17 am

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Akanda, VolitionRX, Virpax Pharmaceuticals, Cue Health, Longeveron Inc. - Subscription Right, and AIM ImmunoTech saw increases, while XBiotech, Carmell Therapeutics, Novo Integrated Sciences, EyePoint Pharmaceuticals, Orgenesis, and Yield10 Bioscience experienced decreases.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 9:31 pm

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Notable gainers included Axcella Health (AXLA), Carmell Therapeutics (CTCX), ContraFect (CFRX), Infinity Pharmaceuticals (INFI), Beyond Air (XAIR), and Healthcare Triangle (HCTI). On the other hand, FibroGen (FGEN), TransCode Therapeutics (RNAZ), Precipio (PRPO), AEON Biopharma (AEON), Vaccinex (VCNX), and NanoVibronix (NAOV) saw their stocks decline.

Portfolio Pulse from Benzinga Insights

August 29, 2023 | 9:31 pm

Shares of several companies including Novo Integrated Sciences, EBET, DLocal Limited, Precision BioSciences, T2 Biosystems, STRATA Skin Sciences, The Alkaline Water Company, Lineage Cell Therapeutics, Tivic Health Systems, and Biophytis S.A. are trading higher in pre-market due to various reasons such as better-than-expected financial results, strategic transactions, and strong quarterly results. On the other hand, shares of Sacks Parente Golf, Coherent Corp., Castellum, Greenbrook TMS, Carmell Therapeutics Corporation, SRM Entertainment, SCYNEXIS, Tower Semiconductor, Trevena, and Mercury Systems are trading lower in pre-market due to reasons such as downbeat quarterly results, pricing of IPO, termination of merger deal, and weak forecasts.

Portfolio Pulse from Lisa Levin

August 16, 2023 | 12:19 pm

During Friday's session, 157 stocks hit new 52-week lows. Among the notable companies were Corteva, American Rebel Holdings, Mullen Automotive, and BNY Mellon Strategic. The stocks that created new 52-week lows on Friday included Avangrid, SolarEdge Technologies, Etsy, UGI, Concentrix, Hawaiian Electric Indus, Equity Commonwealth, Forward Air, Cracker Barrel Old, Petco Health and Wellness, JinkoSolar Holding Co, Olaplex Hldgs, Frontier Group Holdings, Impinj, Safehold, Monro, 3D Sys, TDCX, Everbridge, Silk Road Medical, Cassava Sciences, 23andMe Holding, Wolverine World Wide, Avidity Biosciences, Boston Omaha, John Hancock Premium Div, BioLife Solns, Seres Therapeutics, American Well, Materialise, BNY Mellon Strategic, Southland Holdings, Funko, Fate Therapeutics, Citizens Financial Servs, American Lithium, Emergent BioSolutions, PetMed Express, Sutro Biopharma, Hippo Holdings, Largo, Omega Therapeutics, System1, Benson Hill, Eaton Vance Municipal, Vor Biopharma, Star Hldgs, Origin Mat, Joint, NanoString Technologies, Codexis, ContextLogic, Akoustis Technologies, Cano Health, GeneDx Hldgs, Electrovaya, Kezar Life Sciences, ProPhase Labs, Alaunos Therapeutics, Chimerix, Electriq Power Holdings, DZS, Streamline Health Solns, Eargo, Intercure, Prime Number Acquisition, REE Automotive, TD Hldgs, Carmell Therapeutics, Neuronetics, Kaixin Auto Hldgs, Crown Crafts, Airgain, Ohmyhome, Singular Genomics Sys, First Seacoast Bancorp, Sarcos Technology, Coya Therapeutics, Otonomo Technologies, CareCloud, Aterian, PAVmed, Orgenesis, CalAmp, Imperial Ptrl, Fitell, LQR House, Iridex, OMNIQ, Safeguard Scientifics, Lichen China, Origin Agritech, Atreca, Sunlight Finl Hldgs, Yunji, MediaCo Holding, Trio Petroleum, Cineverse, Lucy Scientific Discovery, Remark Hldgs, Shuttle Pharmaceuticals, Hempacco, Finch Therapeutics Gr, Visionary Education Tech, Marpai, Ontrak, Nogin, Adamis Pharmaceuticals, China Jo-Jo Drugstores, ABVC BioPharma, Fangdd Network Group, SeaStar Medical Holding, Yoshiharu Global, Universe Pharmaceuticals, Redhill Biopharma, Jiuzi Hldgs, Power REIT, Soligenix, Eightco Holdings, JanOne, Avalo Therapeutics, Yield10 Bioscience, Aditxt, Salarius Pharmaceuticals, China Pharma Holding, OpGen, Akanda, Harbor Custom Dev, Biocept, NeuBase Therapeutics, Ucommune International, INVO Bioscience, Esports Entertainment, American Rebel Holdings.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:01 pm

The article lists the stocks that gained and lost the most during Friday's mid-day trading session. Among the gainers were Unique Fabricating, Reata Pharmaceuticals, and Bluejay Diagnostics, while the losers included Tonix Pharmaceuticals, Sleep Number Corporation, and Femasys Inc. Avantor shares fell by 9.9% due to worse-than-expected Q2 financial results.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 5:07 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.